Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Certain black hairstyling practices increase the risk of traction alopecia, requiring better management and education.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

Cetuximab can cause eyelash growth, which is rare but manageable.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The document concludes that hair follicular unit transplantation is an effective method for eyebrow and eyelash reconstruction, with patients happy despite needing regular trimming.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia areata greatly affects people's life quality, mental health, and work life.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Cetuximab can cause unusual hair growth and hair loss.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Rosemary oil may effectively treat hair loss with fewer side effects, but more research is needed.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Topical tofacitinib is effective and safe for treating alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

New treatments for alopecia areata show promise, but standardized guidelines are needed.